Rafaela Dumas

Title: Rafaela Dumas: Innovator in Immunogenic Composition

Introduction

Rafaela Dumas is a prominent inventor based in Porquerolles, France. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human cytomegalovirus (HCMV). With a total of 2 patents, her work is paving the way for advancements in vaccine technology.

Latest Patents

Rafaela Dumas holds two notable patents related to immunogenic compositions for HCMV. The first patent describes an immunogenic composition that includes an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen, and a Th1-inducing adjuvant. This composition is intended for use as an HCMV vaccine. The second patent also focuses on an immunogenic composition comprising the HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant, further emphasizing its application as an HCMV vaccine.

Career Highlights

Rafaela Dumas is currently associated with Sanofi Pasteur Inc., a leading company in the field of vaccines. Her work at Sanofi Pasteur has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Pascal Chaux and Jean Haensler. Their collaboration has been instrumental in advancing the research and development of immunogenic compositions.

Conclusion

Rafaela Dumas is a key figure in the development of innovative immunogenic compositions for HCMV vaccines. Her contributions are vital to the ongoing efforts in vaccine research and development.